BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Punjab Province in Pakistan Signs Agreement With Novartis Access Against Chronic Diseases

  Poor patients in the province of Punjab will soon have free access to high-quality medicines from the Novartis Access portfolio targeting four key noncommunicable disease areas.

  November 13, 2017

   · 

  6 min read
• BioMidwest

  Merck Animal Health Announces Increase in Funding for Veterinary Student Scholarship Program

  Merck Animal Health has announced an increase of $115,000 in funding for its Veterinary Student Scholarship Program.

  November 13, 2017

   · 

  3 min read
• Business

  Orexigen Therapeutics Announces Third Quarter 2017 Financial Results

  Total operating expenses for the third quarter of 2017 were $37.6M compared to a credit of $37.5M for the third quarter of 2016.

  November 13, 2017

   · 

  24 min read
• Business

  Yew Bio-Pharm Group Reports 2017 Third Quarter Financial Results

  For the 2017 third quarter, gross profit was $749,916, or 6.5% of total revenues, compared with $1.4M, or 9.7% of total revenues for the comparable 2016 quarter.

  November 13, 2017

   · 

  32 min read
• Business

  Myovant Sciences Provides Corporate Update and Reports Financial Results for Second Fiscal Quarter Ended September 30, 2017

  R&D expenses for the quarter ended September 30, 2017 were$24.4M, compared to $3.8M for the comparable period in 2016.

  November 13, 2017

   · 

  16 min read
• Genetown

  Myomo Files Registration Statement for Proposed Follow-On Offering

  Myomo, a commercial stage medical robotics company, announced the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase common stock.

  November 13, 2017

   · 

  3 min read
• Business

  Alpine Immune Sciences Reports Corporate Update and Third Quarter 2017 Financial Results

  Alpine ended the third quarter of 2017 with $87.2 million in cash, cash equivalents, and short-term investments compared to $11.8 million as of December 31, 2016.

  November 13, 2017

   · 

  9 min read
• Genetown

  Sage Therapeutics Announces Proposed Public Offering of $300.0 million of Common Stock

  Sage also intends to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of its common stock offered in the public offering. A

  November 13, 2017

   · 

  4 min read
• Business

  OncoSec Receives $9.3M Warrant Exercise

  OncoSec Medical announced today that it has entered into entered into a Warrant Exercise Agreement with certain holders of outstanding warrants to purchase up to an aggregate of 5,509,642 shares of the Company’s common stock, at its stated exercise price of $1.69 per share.

  November 13, 2017

   · 

  3 min read
• Drug Development

  Puma Biotechnology’s 5-Year Analysis of Phase III ExteNET Study Published Online in The Lancet Oncology

  Puma Biotechnology announced the publication of previously presented results from the ExteNET Phase III clinical trial of Puma’s drug neratinib in patients with early stage HER2-positive breast cancer in the journal The Lancet Oncology.

  November 13, 2017

   · 

  10 min read